Clinical Research Center for Allergology and Rheumatology Sagamihara National Hospital Sagamihara Japan

Sagamihara, Japan

Clinical Research Center for Allergology and Rheumatology Sagamihara National Hospital Sagamihara Japan

Sagamihara, Japan
SEARCH FILTERS
Time filter
Source Type

Sekiya K.,Toho University | Nakatani E.,Translational Research Informatics Center Foundation for Biomedical Research and Innovation Kobe Japan | Fukutomi Y.,Clinical Research Center for Allergology and Rheumatology Sagamihara National Hospital Sagamihara Japan | Kaneda H.,Translational Research Informatics Center Foundation for Biomedical Research and Innovation Kobe Japan | And 7 more authors.
Clinical and Experimental Allergy | Year: 2016

Background: Severe or life-threatening asthma exacerbation is one of the worst outcomes of asthma because of the risk of death. To date, few studies have explored the potential heterogeneity of this condition. Objectives: To examine the clinical characteristics and heterogeneity of patients with severe or life-threatening asthma exacerbation. Methods: This was a multicentre, prospective study of patients with severe or life-threatening asthma exacerbation and pulse oxygen saturation < 90% who were admitted to 17 institutions across Japan. Cluster analysis was performed using variables from patient- and physician-orientated structured questionnaires. Results: Analysis of data from 175 patients with severe or life-threatening asthma exacerbation revealed five distinct clusters. Cluster 1 (n = 27) was younger-onset asthma with severe symptoms at baseline, including limitation of activities, a higher frequency of treatment with oral corticosteroids and short-acting beta-agonists, and a higher frequency of asthma hospitalizations in the past year. Cluster 2 (n = 35) was predominantly composed of elderly females, with the highest frequency of comorbid, chronic hyperplastic rhinosinusitis/nasal polyposis, and a long disease duration. Cluster 3 (n = 40) was allergic asthma without inhaled corticosteroid use at baseline. Patients in this cluster had a higher frequency of atopy, including allergic rhinitis and furred pet hypersensitivity, and a better prognosis during hospitalization compared with the other clusters. Cluster 4 (n = 34) was characterized by elderly males with concomitant chronic obstructive pulmonary disease (COPD). Although cluster 5 (n = 39) had very mild symptoms at baseline according to the patient questionnaires, 41% had previously been hospitalized for asthma. Conclusions & Clinical Relevance: This study demonstrated that significant heterogeneity exists among patients with severe or life-threatening asthma exacerbation. Differences were observed in the severity of asthma symptoms and use of inhaled corticosteroids at baseline, and the presence of comorbid COPD. These findings may contribute to a deeper understanding and better management of this patient population. © 2016 The Authors. Clinical & Experimental Allergy Published by John Wiley & Sons Ltd.

Loading Clinical Research Center for Allergology and Rheumatology Sagamihara National Hospital Sagamihara Japan collaborators
Loading Clinical Research Center for Allergology and Rheumatology Sagamihara National Hospital Sagamihara Japan collaborators